Insider Selling: Hinge Health (NYSE:HNGE) Director Sells 1,200 Shares

Hinge Health Inc. (NYSE:HNGE) Director Kristina Leslie sold 1,200 shares of the firm’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $88.23, for a total value of $105,876.00. Following the transaction, the director owned 30,387 shares in the company, valued at approximately $2,681,045.01. This trade represents a 3.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Hinge Health Stock Up 3.3%

Shares of NYSE:HNGE traded up $2.82 during trading on Friday, reaching $88.44. 1,420,005 shares of the company traded hands, compared to its average volume of 1,525,836. The company’s 50 day moving average is $80.94 and its two-hundred day moving average is $58.07. The firm has a market capitalization of $7.14 billion, a PE ratio of 69.09 and a beta of 1.30. Hinge Health Inc. has a 52 week low of $30.08 and a 52 week high of $93.13.

Hinge Health (NYSE:HNGE) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.31. The company had revenue of $212.82 million for the quarter. Hinge Health had a return on equity of 51.60% and a net margin of 15.15%.The firm’s revenue for the quarter was up 53.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.59 EPS. As a group, research analysts anticipate that Hinge Health Inc. will post 1.25 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Stifel Nicolaus set a $96.00 price target on shares of Hinge Health in a research report on Wednesday, August 5th. Needham & Company LLC raised their target price on Hinge Health from $76.00 to $97.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Zacks Research cut Hinge Health from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Wall Street Zen lowered Hinge Health from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Morgan Stanley boosted their target price on Hinge Health from $72.00 to $108.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $100.57.

Institutional Trading of Hinge Health

A number of hedge funds have recently made changes to their positions in the company. BIT Capital GmbH increased its stake in shares of Hinge Health by 79.3% in the fourth quarter. BIT Capital GmbH now owns 3,316,101 shares of the company’s stock valued at $154,033,000 after buying an additional 1,466,577 shares during the period. Vanguard Group Inc. boosted its position in Hinge Health by 110.5% during the 4th quarter. Vanguard Group Inc. now owns 2,605,532 shares of the company’s stock worth $121,027,000 after buying an additional 1,367,693 shares during the period. 11.2 Capital Management LLC acquired a new stake in Hinge Health during the 2nd quarter worth approximately $204,566,531,000. Tiger Global Management LLC grew its holdings in Hinge Health by 227.1% during the 4th quarter. Tiger Global Management LLC now owns 1,805,751 shares of the company’s stock worth $83,877,000 after acquiring an additional 1,253,743 shares during the last quarter. Finally, Millennium Management LLC raised its stake in shares of Hinge Health by 225.0% during the fourth quarter. Millennium Management LLC now owns 1,479,642 shares of the company’s stock valued at $68,729,000 after acquiring an additional 1,024,317 shares during the last quarter.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.